Archives of Sexual Behavior

, Volume 25, Issue 4, pp 341–360 | Cite as

Effectiveness of yohimbine in the treatment of erectile disorder: Four meta-analytic integrations

  • Michael P. Carey
  • Blair T. Johnson


The results of four independent yet convergent meta-analyses to examine the efficacy of yohimbine in the treatment of erectile disorder are reported. These meta-analyses integrated data from (i) controlled clinical trials of yohimbine (when used alone), (ii) uncontrolled trials examining yohimbine (alone), (iii) controlled trials of yohimbine when used in combination with other drugs, and (iv) uncontrolled trials of yohimbine plus other drugs. Results document a consistent tendency for yohimbine, and for other medications containing yohimbine, to enhance erectile functioning relative to placebo. We also identify methodological and reporting difficulties that characterize much of the literature.

Key Words

yohimbine erectile disorder impotence treatment meta-analysis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Psychiatric Association. (1994).Diagnostic and Statistical Manual of Mental Disorders, 4th ed., American Psychiatric Association, Washington, DC.Google Scholar
  2. Barnes, D. M. (1986). Promising results halt trial of anti-AIDS drug.Science 234: 15–16.PubMedGoogle Scholar
  3. Carey, M. P., Lantinga, L. J., and Krauss, D. J. (1994). Male erectile disorder. In Ammerman, R. T., and Hersen, M. (eds.),Handbook of Prescriptive Treatments for Adults, Plenum Press, New York, pp. 347–367.Google Scholar
  4. Centers for Disease Control Veteran Experience Study. (1988). Health status of Vietnam veterans: I. Psychosocial characteristics.J. Am. Med. Assoc. 259: 2701–2707.CrossRefGoogle Scholar
  5. Cooper, A. J., Smith, C. G., Ismail, A. A. A., and Loraine, J. A. (1973). A controlled trial of Potensan Forte (“Aphrodisiac” and testosterone combined) in impotence.Irish J. Med. Sci., 142: 155–161.PubMedCrossRefGoogle Scholar
  6. Friesen, K., Palatnick, W., and Tenenbein, M. (1993). Benign course after massive ingestion of Yohimbine.J. Emerg. Med. 11: 287–288.PubMedCrossRefGoogle Scholar
  7. Greenwald, A. G., Spangenberg, E. R., Pratkanis, A. R., and Eskenazi, J. (1991). Double blind tests of subliminal self-help audiotapes.Psychol. Sci. 2: 119–122.CrossRefGoogle Scholar
  8. Haslam, M. T. (1992). A trial of idazoxan and yohimbine in sexual dysfunction.Sex. Marital Ther. 7: 261–266.Google Scholar
  9. Hedges, L. V., and Olkin, I. (1985).Statistical Methods for Meta-Analysis, Academic Press, Orlando, FL.Google Scholar
  10. Hollander, E., and McCarley, A. (1992). Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.J. Clin. Psychiat., 53: 207–209.Google Scholar
  11. Jacobsen, F. M. (1992). Fluoxetine-induced sexual dysfunction and an open trial of Yohimbine.J. Clin. Psychiat. 53: 119–122.Google Scholar
  12. Johnson, B. T. (1993).DSTAT 1.10: Software for the Meta-Analytic Review of Research Literatures, Erlbaum, Hillsdale, NJ.Google Scholar
  13. Johnson, B. T., and Turco, R. M. (1992). The value of goodness-of-fit indices in meta-analysis: A comment on Hall and Rosenthal.Commun. Monogr. 59: 388–396.CrossRefGoogle Scholar
  14. Kinsey, A. C., Pomeroy, W. B., and Martin, C. E. (1948).Sexual Behavior in the Human Male, W. B. Saunders, Philadelphia, PA.Google Scholar
  15. Krane, R. J., Goldstein, I., and Sanenz de Tejada, I. (1989). Impotence.New Engl. J. Med. 321: 1648–1659.PubMedCrossRefGoogle Scholar
  16. Macfarlane, C. A., Reynolds, W. J., and Rosencrantz, D. R. (1983). Yohimbine—An alternative treatment for erectile dysfunction.Wkly. Urol. Clin. Lett., 27: 1.Google Scholar
  17. Malloy, T. R., and Malkowicz, B. (1987). Pharmacologic treatment of impotence.Curr. Med. Ther. Urol. Dis. 14: 297–305.Google Scholar
  18. Margolis, R., and Leslie, C. H. (1966). Review of studies on a mixture of nux vomica, Yohimbine and methyl testosterone in the treatment of impotence.Curr. Ther. Res. 8: 280–284.PubMedGoogle Scholar
  19. Margolis, R., Sangree, H., Prieto, P., Stein, L., and Chinn, S. (1967). Clinical studies on the use of Afrodex in the treatment of impotence: Statistical summary of 4000 cases.Curr. Ther. Res. 9: 213–219.PubMedGoogle Scholar
  20. Margolis, R., Prieto, P., Stein, L., and Chinn, S. (1971). Statistical summary of 10,000 male cases using Afrodex in the treatment of impotence.Curr. Ther. Res. 13: 616–622.PubMedGoogle Scholar
  21. Miller, W. W., Jr. (1968). Afrodex in the treatment of male impotence: A double-blind cross-over study.Curr. Ther. Res., 10: 354–359.PubMedGoogle Scholar
  22. Morales, A., Condra, M., Owen, J. A., Surridge, D. H., Fenemore, J., and Harris C., (1987). Is Yohimbine effective in the treatment of organic impotence? Results of a controlled trial.J. Urol. 137: 1168–1172.PubMedGoogle Scholar
  23. Morales, A., Surridge, D. H., Marshall, P. G., and Fenemore, J. (1982). Nonhormonal pharmacological treatment of organic impotence?J. Urol. 128: 45–47.PubMedGoogle Scholar
  24. National Institutes of Health. (1993). Consensus conference on impotence: Final statement.Int. J. Impotence Res. 5: 181–199.Google Scholar
  25. Pollack, M. H., and Hammerness, P. (1993). Adjunctive Yohimbine for treatment in refractory depression.Biol. Psychiat. 33: 220–221.PubMedCrossRefGoogle Scholar
  26. Price, J., & Grunhaus, L. J. (1990). Treatment of clomipramine-induced anorgasmia with yohimbine: A case report.J. Clin. Psychiat. 51: 32–33.Google Scholar
  27. Quadraccia, A., Salvini, A., Cordani, C., and Pizzi, P. (1988). Yohimbine plus intracavernous vasodilators in mild vasculogenic impotence.Acta Urol. Belg. 56: 272–278.PubMedGoogle Scholar
  28. Reid, K., Surridge, D. H. C., Morales, A., Condra, M., Harris, C., Owen, J., and Fenemore, J. (1987). Double-blind trial of yohimbine in treatment of psychogenic impotence.Lancet 2: 421–423.PubMedCrossRefGoogle Scholar
  29. Riley, A. J., Goodman, R. E., Kellett, J. M., and Orr, R. (1989). Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy.Sex. Marital Ther. 4: 17–26.Google Scholar
  30. Roberts, C. D., and Sloboda, W. (1974). Afrodex vs. placebo in the treatment of male impotence: Statistical analysis of two double-blind crossover studies.Curr. Ther. Res. 16: 96–99.PubMedGoogle Scholar
  31. Rosen, R. C., and Ashton, A. K. (1993). Prosexual drugs: Empirical status of the “New Aphrodisiacs.”Arch. Sex. Behav. 22: 521–543.PubMedCrossRefGoogle Scholar
  32. Sandler, B., and Aronson, P. (1993). Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome.Urology 41: 343–345.PubMedCrossRefGoogle Scholar
  33. Savion, M., Segenreich, E., Kahan, E., and Servadio, C. (1987). Pharmacologic, nonhormonal treatment of impotence: Evaluation of associated factors.Urology 29: 510–512.PubMedCrossRefGoogle Scholar
  34. Segraves, R. T., Knopf, J., and Camic, P. (1982). Spontaneous remission in erectile impotence.Behav. Res. Ther. 20: 89–91.PubMedCrossRefGoogle Scholar
  35. Smith, M. L., and Glass, G. C. (1977). Meta-analysis of psychotherapy outcome studies.Am Psychol. 32: 752–760.PubMedCrossRefGoogle Scholar
  36. Sobotka, J. J. (1969). An evaluation of Afrodex in the management of male impotency: A double-blind crossover study.Curr. Ther. Res. 11: 87–94.PubMedGoogle Scholar
  37. Sonda, L. P., Mazo, R., and Chancellor, M. B. (1990). The role of Yohimbine for the treatment of erectile impotence.J. Sex. Marital Ther. 16: 15–21.PubMedGoogle Scholar
  38. Spector, I. P., and Carey, M. P. (1990). Incidence and prevalence of the sexual dysfunctions: A critical review of the literature.Arch. Sex. Behav. 19: 389–408.PubMedCrossRefGoogle Scholar
  39. Steering Committee of the Physicians Health Study Research Group. (1988). Preliminary report: Findings from the aspirin component of the ongoing physicians' health study.New Engl. J. Med. 318: 262–264.CrossRefGoogle Scholar
  40. Susset, J. G., Tessier, C. D., Wincze, J., Bansal, S.,Malhotra, C., and Schwacha, M. G. (1989). Effect of Yohimbine hydrochloride on erectile impotence: A double-blind study.J. Urol. 141: 1360–1363.PubMedGoogle Scholar
  41. Vickers, M. A., Jr., de Nobrega, A. M., and Dluhy, R. G. (1993). Diagnosis and treatment of psychogenic erectile dysfunction in a urological setting: Outcomes of 18 consecutive patient.J. Urol. 149: 1258–1261.PubMedGoogle Scholar
  42. Wolpowitz, A., and Barnard, C. N. (1978). Impotence after heart transplantation [letter].S. Afr. Med. J. 53: 693.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • Michael P. Carey
    • 1
    • 2
    • 3
  • Blair T. Johnson
    • 1
  1. 1.Department of Psychology and Center for Health and BehaviorSyracuse UniversitySyracuse
  2. 2.Psychology ServiceDepartment of Veterans Affairs Medical CenterSyracuse
  3. 3.Department of UrologySUNY Health Science Center at SyracuseSyracuse

Personalised recommendations